Dr Simon Mendelsohn

With an MBChB, MSc, DTM&H, Simon’s research focuses on developing and validating novel tools for diagnosing persistent Mycobacterium tuberculosis (M. tb) infection, incipient and sub-clinical tuberculosis (TB) disease, monitoring response to TB treatment, and biomarker-guided TB preventive and curative therapy. He is part of the South African Tuberculosis Vaccine Initiative (SATVI).